Deregulation of anaphase-promoting complex/cyclosome-dependent proteolysis in cancer

Journal of Oral Biosciences

Volumn 52, Issue 4, 2010, Pages 388-401

  Kudo, Yasusei ^a   Tsunematsu, Takaaki ^a   Takata, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer; Cell cycle; Proteolysis; Ubiquitin

Indexed keywords

EID: 79952240855     PISSN: 13490079     EISSN: None     Source Type: Journal    
DOI: 10.2330/joralbiosci.52.388     Document Type: Review

References (110)

1. Fearon, E. R. and Vogelstein, B. : A genetic model for colorectal tumorigenesis. Cell 61 : 759-767, 1990.
2. Marx, J. : Many gene changes found in cancer. Science 246 : 1386-1388, 1989. (Pubitemid 20018310)
3. Sherr, C.J. : G1 phase progression : cycling on cue. Cell 79 : 551-555, 1994.
4. Hunter, T. and Pines, J. : Cyclins and cancer II : cyclin D and CDK inhibitors come of age. Cell 79 : 573-582, 1994. (Pubitemid 24363801)
5. Slingerland, J. M. and Pagano, M. : Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183 : 10-17, 2000. (Pubitemid 30130220)
6. Morgan, M. : Principles of cdk regulation. Nature 374 : 131-134, 1995.
7. Sherr, C. J. and Roberts, J. M. : Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 : 1149-1163, 1995.
8. Sherr, C. J. and Roberts, J. M. : CDK inhibitors : positive and negative regulators of G1-phase progression. Genes Dev. 13 : 1501-1512, 1999. (Pubitemid 29297917)
9. Sherr, C.J. : Mammalian G1 cyclins. Cell 73 : 1059-1065, 1993.
10. Serrano, M., Hannon, G. J. and Beach, D. : A new regulatory motif in cell-cycle control causing spe-cific inhibition of cyclin D/CDK4. Nature 366 : 704 707, 1993. (Pubitemid 24036021)
11. Hannon, G.J. and Beach, D. : p15INK4B is a potent effector of TGF-beta-induced cell cycle arrest. Nature 371 : 257-261, 1994.
12. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K, Tavtigian, S. V, Stockert, E., Day, R S. IE, Johnson, B. E. and Skolnick, M. H. : A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 : 436-440, 1994.
13. Nobori, T, Miura, K, Wu, D.J., Lois, A., Takabayashi, K. and Carson, D. A. : Delations of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 : 753-756, 1994. (Pubitemid 24153417)
14. El-Deiry W. S., Tokino, T, Velculescu, V.E., Levy, D. B., Persons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. : WAF1, a potential mediator of p53 tumor suppression. Cell 75 : 817-825, 1993. (Pubitemid 23346378)
15. Harper, J. W., Adami, G. R., Wei, N, Keyomarsi, K. and Elledge, S.J. : The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 : 805-816, 1993. (Pubitemid 23346377)
16. Kip1, a cyclin-Cdk inhibitor, links transforming growth fac:tor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8 : 9-22, 1994.
17. Toyoshima, H. and Hunter, T : p27, a novel inhibi-tor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 : 67-74, 1994. (Pubitemid 24228301)
18. Peters, J. M. : The anaphase promoting complex/ cyclosome : a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 7 : 644-656, 2006.
19. Cardozo, T and Pagano, M. : The SCF ubiquitin ligase : insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5 : 739-751, 2004. (Pubitemid 39208183)
20. Hanahan, D. and Weinberg, R A. : The hallmarks of cancer. Cell 100 : 57-70, 2000. (Pubitemid 30046295)
21. Ang, X. and Harper, J. W : SCF-mediated protein degradation and cell cycle control. Oncogene 24 : 2860-2870, 2005. (Pubitemid 40638095)
22. Bashir, T and Pagano, M. : Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis. Adv. Cancer Res. 88 : 101-144, 2003. (Pubitemid 36343280)
23. Pagano, M. and Benmaamar, R. : When protein destruction runs amok, malignancy is on the loose. Cancer Cell 4 : 251-256, 2003. (Pubitemid 37329789)
24. Reed, S. : Ratchets and clocks : the cell cycle, ubiquitylation and protein turnover. Nat. Rev. Mol. Cell Biol. 4 : 855-864, 2003. (Pubitemid 37411724)
25. Yamasaki, L. and Pagano, M. : Cell cycle, proteolysis and cancer. Curr. Opin. Cell Biol. 16 : 623-628, 2004. (Pubitemid 39463111)
26. Nakayama, K. I. and Nakayama, K. : Ubiquitin ligases : cell-cycle control and cancer. Nat. Rev. Can:cer 6 : 369-381, 2006.
27. He, N, Li, C, Zhang, X., Sheng, T, Chi, S., Chen, K, Wang, Q., Vertrees, R, Logrono, R. and Xie, J. : Regulation of lung cancer cell growth and invasive-ness by /TTRCP. Mol. Carcinog. 42 : 18-28, 2005. (Pubitemid 40041482)
28. Koch, A., Waha, A., Hartmann, W, Hrychyk, A., Schuller, U., Wharton, K. A., Jr., Fuchs, S. Y., von Schweinitz, D. and Pietsch, T. : Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clin. Cancer Res. 11 : 4295-4304, 2005. (Pubitemid 40825616)
29. Kudo, Y., Guardavaccaro, D., Santamaria, P. G., Koyama-Nasu, R., Latres, E., Bronson, R., Yamasaki, L. and Pagano, M. : Role of F-box protein betaTrcp1 in mammary gland development and tumorigenesis. Mol. Cell Biol. 24 : 8184-8194, 2004. (Pubitemid 39167466)
30. Ougolkov, A., Zhang, B., Yamashita, K., Bilim, V, Mai, M., Fuchs, S. Y and Minamoto, T. : Associa:tions among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer. J. Natl. Cancer Inst. 96 : 1161-1170, 2004. (Pubitemid 39207052)
31. Zhou, B. E and Hung, M. C. : Wnt, hedgehog and snail : sister pathways that control by GSK-3/J and /3Trcp in the regulation of metastasis. Cell Cycle 4 : 772-776, 2005.
32. Kudo, Y, Takata, T., Yasui, W Ogawa, I., Miyauchi, M., Takekoshi, T., Tahara, E. and Nikai, H. : Reduced expression of cyclin- dependent kinase inhibitor p27Kip1 is an indicator of malignant behav:ior of oral squamous cell carcinomas. Cancer 83 : 2447-2466, 1998.
33. Kudo, Y, Takata, T., Ogawa, I., Sato, S., Kaneda, T., Takekoshi, T, Zhao, M., Miyauchi, M. and Nikai, H. : p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clin. Cancer Res. 6 : 916-923, 2000. (Pubitemid 30159349)
34. Kudo, Y, Kitajima, S., Ogawa, I., Sato, S., Miyauchi, M. and Takata, T : High expression of Skp2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 61 : 7044-7077, 2001.
35. Kitajima, S., Kudo, Y, Ogawa, I., Bashir, T, Kitaga-wa, M., Miyauchi, M., Pagano, M. and Takata, T : Role of Cks1 overexpression in oral squamous cell carcinomas : cooperation with Skp2 in promoting p27 degradation. Am. J. Pathol. 165 : 2147-2155, 2004. (Pubitemid 39578391)
36. Hershko, A. and Ciechanover, A. : The ubiquitin system. Annu. Rev. Biochem. 67 : 425-479, 1998. (Pubitemid 28411135)
37. Schwab, M., Neutzner, M., Mocker, D. and Seufert, W . : Yeast Hct1 recognizes the mitotic cyclin Clb2 and other substrates of the ubiquitin ligase APC. EMBO J. 20 : 5165-5175, 2001. (Pubitemid 32910911)
38. Passmore, L. A., McCormack, E. A., Au, S. W, Paul, A., Willison, K. R., Harper, J. W and Barford, D. : Doc1 mediates the activity of the anaphasepro: Moting complex by contributing to substrate recognition. EMBO J. 22 : 786-796, 2003. (Pubitemid 36227781)
39. Vodermaier, H. C, Gieffers, C, Maurer-Stroh, S., Eisenhaber, F. and Peters, J. M. : TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1. Curr. Biol. 13 : 1459-1468, 2003. (Pubitemid 37078402)
40. Kraft, C, Vodermaier, H. C, Maurer-Stroh, S., Ei-senhaber, F. and Peters, J. M. : The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol. Cell 18 : 543-553, 2005. (Pubitemid 40726231)
41. Glotzer, M., Murray, A. W and Kirschner, M. W : Cyclin is degraded by the ubiquitin pathway. Nature 349 : 132-138, 1991. (Pubitemid 21912025)
42. Pfleger, C. M. and Kirschner, M. W : The KEN box : an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev. 14 : 655-665, 2000. (Pubitemid 30176820)
43. Castro, A., Vigneron, S., Bernis, C, Labbe, J. C, Prigent, C. and Lorca, T : The D-Box-activating domain (DAD) is a new proteolysis signal that stimulates the silent D-Box sequence of Aurora-A. EMBO Rep. 3 : 1209-1214, 2002. (Pubitemid 36105012)
44. Littlepage, L. E. and Ruderman, J. V : Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruc:tion of the kinase Aurora-A during mitotic exit. Genes Dev. 16 : 2274-2285, 2002. (Pubitemid 35013090)
45. Reis, A., Levasseur, M., Chang, H. Y, Elliott, D.J. and Jones, K. T : The CRY box : a second APCcdh1-dependent degron in mammalian cdc20. EMBO Rep. 7 : 1040-1045, 2006. (Pubitemid 44480521)
46. Castro, A., Vigneron, S., Bernis, C, Labbe, J. C. and Lorca, T : Xkid is degraded in a D-box, KEN-box, and A-box-independent pathway. Mol. Cell. Biol. 23 : 4126-4138, 2003. (Pubitemid 36666418)
47. Sullivan, M. and Morgan, D. O. : A novel destruction sequence targets the meiotic regulator Spo13 dor anaphase-promoting complex-dependent degradation in anaphase I.J. Biol. Chem. 282 : 19710-19715, 2007. (Pubitemid 47100102)
48. Araki, M., Wharton, R. P., Tang, Z., Yu, H. and Asano, M. : Degradation of origin recognition complex large subunit by the anaphase-promoting complex in Drosophila. EMBO J. 22 : 6115-6126, 2003. (Pubitemid 37463254)
49. Guardavaccaro, D. and Pagano, M. : Stabilizers and destabilizers controlling cell cycle oscillators. Mol. Cell 22 : 1-4, 2006.
50. Mailand, N. and Diffley, J. E : CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 122 : 915-926, 2005. (Pubitemid 41345208)
51. Lin, H. K., Wang, G., Chen, Z., Teruya-Feldstein, J., Liu, Y., Chan, C. H., Yang, W. L., Erdjument-Bromage, H., Nakayama, K. I., Nimer, S., Tempst, P. and Pandolfi, P. P. : Phosphorylation -dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat. Cell Biol. 11 : 420-432, 2009.
52. Choi, E., Choe, H., Min, J., Choi, J. Y, Kim, J. and Lee, H. : BubR1 acetylation at prometaphase is required for modulating APC/C activity and timing of mitosis. EMBO J. 28 : 2077-2089, 2009.
53. Rape, M., Reddy S. K and Kirschner, M. W. : The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124 : 89-103, 2006. (Pubitemid 43069312)
54. Wolthuis, R, Clay-Farrace, L., van Zon, W., Yekezare, M., Koop, L, Ogink, J., Medema, R. and Pines, J. : Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. Mol. Cell. 30 : 290-302, 2008. (Pubitemid 351615313)
55. Wang, Q., Moyret-Lalle, Q., Couzon, F., Surbiguet-Clippe, C, Saurin, J. C, Lorca, T., Navarro, C. and Puisieux, A. : Alterations of anaphase promoting complex genes in human colon cancer cells. Oncogene 22 : 1486-1490, 2003. (Pubitemid 36390597)
56. Zachariae, W and Nasmyth, K. : TPR proteins required for anaphase progression mediate ubiquitination of mitotic Btype cyclins in yeast. Mol. Biol. Cell 7 : 791-801, 1996. (Pubitemid 26139275)
57. Wang, C. X., Fisk, B. C, Wadehra, M., Su, H. and Braun, J. : Overexpression of murine fizzy-related (fzr) increases natural killer cell-mediated cell death and suppresses tumor growth. Blood 96 : 259-263, 2000. (Pubitemid 30456479)
58. Engelbert, D., Schnerch, D., Baumgarten, A. and Wasch, R : The APCcd is required to maintein genome integrity in primary human cells. Oncogene 27 : 907-917, 2008. (Pubitemid 351225382)
59. Hsu, J. Y, Reimann, J. D., Sorensen, C. S., Lukas, J. and Jackson, P. K. : E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC (Cdh1). Nat. Cell Biol. 4 : 358-366, 2002. (Pubitemid 34521031)
60. Hernando, E., Nahle, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L, Mittal, V, Gerald, W and Benezra, R : Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430 : 797-802, 2004. (Pubitemid 39071352)
61. Reimann, J. D., Gardner, B. E., Margottin-Goguet, F . and Jackson, P. K. : Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 15 : 3278-3285, 2001. (Pubitemid 34013499)
62. Reimann, J. D., Freed, E., Hsu, J. Y, Kramer, E. R., Peters, J. M. and Jackson, P. K : Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105 : 645-655, 2001. (Pubitemid 32524117)
63. Alizadeh, A. A., Eisen, M. B., Davis, R E., Ma, C, Lossos, I. S., Rosenwald, A., Boldrick, J. C, Sabet, H, Tran, T and Yu, X. : Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 : 503-511, 2000. (Pubitemid 30082188)
64. Chen, X., Cheung, S. T, So, S., Fan, S. T, Barry, C, Higgins, J., Lai, K. M., Ji, J., Dudoit, S. and Ng, I. O. : Gene expression patterns in human liver cancers. Mol. Biol. Cell 13 : 1929-1939, 2002. (Pubitemid 34651483)
65. Garber, M. E., Troyanskaya, O. G., Schluens, K, Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M. and Whyte, R I. : Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 98 : 13784-13789, 2001. (Pubitemid 33115976)
66. Li, G. Q., Li, H. and Zhang, H. E : Mad2 and p53 expression profiles in colorectal cancer and its clinical significance. World J. Gastroenterol. 9 : 1972-1975, 2003. (Pubitemid 37168424)
67. Tanaka, K, Nishioka, J., Kato, K, Nakamura, A., Mouri, T, Miki, C, Kusunoki, M. and Nobori, T : Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn. J. Cancer Res. 92 : 952-958, 2001. (Pubitemid 32970436)
68. van't Veer, L J., Dai, H., van de Vijver, M. J., He, Y D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy K, Marton, M.J. and Witteveen, A. T : Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 : 530-536, 2002. (Pubitemid 34130608)
69. Sotillo, R., Hernando, E., Díaz-Rodríguez, E., Teruya-Feldstein, J., Cordón-Cardo, C, Lowe, S. W and Benezra, R. : Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11 : 9-23, 2007. (Pubitemid 46054519)
70. Margottin-Goguet, F., Hsu, J. Y, Loktev, A., Hsieh, H. M., Reimann, J. D. and Jackson, P. K. : Prophase destruction of Emi1 by the SCF (betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4 : 813-826, 2003. (Pubitemid 36676034)
71. Guardavaccaro, D., Kudo, Y., Boulaire, J., Barchi, M., Busino, L., Donzelli, M., Margottin-Goguet, F., Jackson, P. K., Yamasaki, L. and Pagano, M. : Control of meiotic and mitotic progression by the F box pro:tein y3-Trcp1 in vivo. Dev. Cell 4 : 799-812, 2003. (Pubitemid 36676033)
72. Lehman, N. L., Tibshirani, R., Hsu, J. Y, Natkunam, Y, Harris, B. T., West, R B., Masek, M. A., Montgomery, K., van de Rijn, M. and Jackson, P. K. : Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am. J. Pathol. 170 : 1793-1805, 2007. (Pubitemid 47339321)
73. Gütgemann, I., Lehman, N. L., Jackson, P. K. and Longacre, T A. : Emi1 protein accumulation implicates misregulation of the anaphase promoting com-plex/cyclosome pathway in ovarian clear cell carcinoma. Mod. Pathol. 21 : 445-454, 2008. (Pubitemid 351441034)
74. Lehman, N. L., Verschuren, E. W., Hsu, J. Y, Cherry, A. M. and Jackson, P. K. : Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53- deficient cells. Cell Cycle 5 : 1569-1573, 2006. (Pubitemid 44091978)
75. Liu, A. W., Cai, J., Zhao, X. L., Xu, A. M., Fu, H. Q., Nian, H. and Zhang, S. H. : The clinicopathological significance of BUBR1 overexpression in hepatocel:lular carcinoma. J. Clin. Pathol. 62 : 1003-1008, 2009.
76. Lee, Y K., Choi, E., Kim, M. A., Park, P. G., Park, N. H. and Lee, H. : BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers. Br. J. Cancer 101 : 504-510, 2009.
77. Pinto, M., Vieira, J., Ribeiro, F.R, Soares, M. J., Henrique, R., Oliveira, J., Jerónimo, C. and Teixeira, M. R : Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell. Oncol. 30 : 389-395, 2008.
78. Yamamoto, Y, Matsuyama, H., Chochi, Y, Okuda, M., Kawauchi, S., Inoue, R., Furuya, T., Oga, A., Naito, K. and Sasaki, K. : Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet. Cytogenet. 174 : 42-47, 2007. (Pubitemid 46365984)
79. Grabsch, H., Takeno, S., Parsons, W. J., Pomjanski, N., Boecking, A., Gabbert, H. E. and Mueller, W. : Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer-association with tumour cell proliferation. J. Pathol. 200 : 16-22, 2003. (Pubitemid 36592631)
80. Seike, M., Gemma, A., Hosoya, Y, Hosomi, Y, Okano, T., Kurimoto, F., Uematsu, K, Takenaka, K, Yoshimura, A., Shibuya, M., Ui-Tei, K and Kudoh, S. : The promoter region of the human BUBR1 gene and its expression analysis in lung cancer. Lung Cancer 38 : 229-234, 2002. (Pubitemid 35341797)
81. Song, M.S., Song, S. J., Ayad, N. G., Chang, J. S., Lee, J. H., Hong, H. K, Lee, H., Choi, N, Kim, J., Kim, H., Kim, J. W., Choi, E.J., Kirschner, M. W. and Lim, D. S. : The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat. Cell Biol. 6 : 129-137, 2004. (Pubitemid 38425712)
82. Dammann, R., Li, C, Yoon, J. H., Chin, P. L., Bates, S. and Pfeifer, G E : Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25 : 315-319, 2000. (Pubitemid 30437320)
83. Astuti, D., Agathanggelou, A., Honorio, S., Dallol, A., Martinsson, T, Kogner, P., Cummins, C, Neumann, H. P., Voutilainen, R., Dahia, P., Eng, C, Maher, E. R. and Latif, F. : RASSF1A promoter region CpG island hypermethylation in phaeochro-mocytomas and neuroblastoma tumours. Oncogene 20 : 7573-7577, 2001. (Pubitemid 33086917)
84. Burbee, D. G., Forgacs, E., Zöchbauer-Müller, S., Shivakumar, L, Fong, K, Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., Sekido, Y, Latif, F., Milchgrub, S., Toyooka, S., Gazdar, A. F., Lerman, M. I., Zabarovsky E., White, M. and Minna, J. D. : Epi:genetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93 : 691-699, 2001. (Pubitemid 32492810)
85. Dammann, R., Takahashi, T and Pfeifer, G E : The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 20 : 3563-3567, 2001. (Pubitemid 32619409)
86. Dreijerink, K, Braga, E., Kuzmin, I., Geil, L, Duh, F. M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., Protopopov, A., Li, J., Kashuba, V, Klein, G. and Zabarovsky, E. R. : The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. USA 98 : 7504-7509, 2001. (Pubitemid 32567978)
87. Lo, K. W., Kwong, J., Hui, A. B., Chan, S. Y., To, K. F., Chan, A. S., Chow, L. S., Teo, P. M., Johnson, P. J. and Huang, D. E : High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res. 61 : 3877-3881, 2001. (Pubitemid 32720944)
88. Kitajima, S., Kudo, Y, Ogawa, I., Tatsuka, M., Kawai, H., Pagano, M. and Takata, T. : Constitutive phosphorylation of aurora-a on ser51 induces its stabilization and consequent overexpression in cancer. PLoS One 2 : e944, 2007.
89. Bischoff, J. R., Anderson, L., Zhu, Y, Mossie, K, Ng, L., Souza, B., Schryver, B., Flanagan, P., Clairvoyant, F., Ginther, C, Chan, C. S., Novotny M., Slamon, D. J. and Plowman, G. D. : A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17 : 3052-3065, 1998. (Pubitemid 28254378)
90. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W, Sahin, A., Brinkley B. R. and Sen, S. : Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20 : 189-193, 1998. (Pubitemid 28455454)
91. Tanner, M. M., Grenman, S., Koul, A., Johannsson, O., Meltzer, P., Pejovic, T, Borg, A. and Isola, J. J. : Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res. 6 : 1833-1839, 2000. (Pubitemid 30305079)
92. Watanabe, T, Imoto, I., Katahira, T, Hirasawa, A., Ishiwata, I., Emi, M., Takayama, M., Sato, A. and Inazawa, J. : Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers. Jpn. J. Cancer Res. 93 : 1114-1122, 2002. (Pubitemid 35314956)
93. Rojanala, S., Han, H., Munoz, R M., Browne, W., Nagle, R., Von Hoff, D. D. and Bearss, D. J. : The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer. Mol. Cancer Ther. 3 : 451-457, 2004. (Pubitemid 39193722)
94. Tatsuka, M., Sato, S., Kitajima, S., Suto, S., Kawai, H, Miyauchi, M., Ogawa, I., Maeda, M., Ota, T and Takata, T : Overexpression of Aurora-A potenti:ates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene 24 : 1122-1127, 2005. (Pubitemid 40313891)
95. Tanaka, T, Kimura, M., Matsunaga, K, Fukada, D., Mori, H. and Okano, Y : Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 59 : 2041-2044, 1999. (Pubitemid 29217660)
96. Takahashi, T, Futamura, M., Yoshimi, N, Sano, J., Katada, M., Takagi, Y, Kimura, M., Yoshioka, T, Okano, Y and Saji, S. : Centrosomal kinases, HsAIRK1 and HsAIRK3, are overexpressed in pri:mary colorectal cancers. Jpn. J. Cancer Res. 91 : 1007-1014, 2000.
97. Gritsko, T M., Coppola, D., Paciga, J. E., Yang, L., Sun, M., Shelley, S. A., Fiorica, J. V, Nicosia, S. V and Cheng, J. Q. : Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin. Cancer Res. 9 : 1420-1426, 2003. (Pubitemid 36418396)
98. Li, D., Zhu, J., Firozi, P. F. , Abbruzzese, J. L., Evans, D. B., Cleary K, Friess, H. and Sen, S. : Overex:pression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. 9 : 991-997, 2003. (Pubitemid 36323702)
99. Reiter, R, Gais, P., Jutting, U., Steuer-Vogt, M. K, Pickhard, A., Bink, S., Rauser, S., Lassmann, H., Hofler, M., Werner, M. and Walch, A. : Aurora kinase a messenger RNA overexpression is corre-lated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin. Cancer Res. 12 : 5136-5141, 2006. (Pubitemid 44453341)
100. Jeng, Y M., Peng, S. Y, Lin, C. Y and Hsu, H. C. : Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin. Cancer Res. 10 : 2065-2071, 2004.
101. Sakakura, C, Hagiwara, A., Yasuoka, R., Fujita, Y, Nakanishi, M., Masuda, K, Shimomura, K, Nakamura, Y, Inazawa, J., Abe, T and Yamagishi, H. : Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84 : 824-831, 2001. (Pubitemid 32275658)
102. Qi, G, Kudo, Y, Ando, T, Siriwardena, B. S. M. S., Yoshida, M., Keikhaee, R. M., Ogawa, I. and Takata, T. : Nuclear Survivin expression is well correlated with Aurora-B expression and malignant behavior of oral cancer. Oral Oncol. 46 : 263-270, 2010.
103. Gassmann, R., Carvalho, A., Henzing, A.J., Ruchaud, S., Hudson, D. F., Honda, R., Nigg, E. A., Gerloff, D. L and Earnshaw, W. C. : Borealin : a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 166 : 179-191, 2004. (Pubitemid 38988771)
104. Lens, S. M., Vader, G. and Medema, R. H. : The case for Survivin as mitotic regulator. Curr. Opin. Cell Biol. 18 : 616-622, 2006. (Pubitemid 44711886)
105. Bolton, M. A., Lan, W., Powers, S. E., McCleland, M. L., Kuang, J. and Stukenberg, P. T. : Aurora B kinase exists in a complex with Survivin and INCENP and its kinase activity is stimulated by Survivin binding and phosphorylation. Mol. Biol. Cell 13 : 3064-3077, 2002. (Pubitemid 35034246)
106. Honda, R., Korner, R. and Nigg, E. A. : Exploring the functional interactions between Aurora B, INCENP, and Survivin in mitosis. Mol. Biol. Cell 14 : 3325-3341, 2003. (Pubitemid 37013130)
107. Adams, R. R., Eckley D. M., Vagnarelli, P., Wheatley S. P., Gerloff, D. L., Mackay A. M., Svingen, P. A., Kaufmann, S. H. and Earnshaw, W. C. : Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells. Chromosome 110 : 65-74, 2001. (Pubitemid 32529710)
108. Beardmore, V.A., Ahonen, L.J., Gorbsky G.J. and Kallio, M. J. : Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule - attachment and Aurora B kinase activity. J. Cell. Sci. 117 : 4033-4042, 2004. (Pubitemid 39328292)
109. Artieri, D. C. : The case for Survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 18 : 609-615, 2006.
110. Murray, A. W. : Recycling the cell cycle : cyclins revisited. Cell 116 : 221-234, 2004. (Pubitemid 38167314)